GLP-1 medications act on both upstream and downstream drivers of neurodegeneration, improving insulin sensitivity, vascular function, and mitochondrial efficiency while also influencing amyloid, tau, neuroinflammation, and synaptic health
The interactions between glutathione and medicines are not fully understood
And even people who interrupted treatment for just six months before resuming saw their cardiovascular benefit reduced from 18% to approximately 12%, a gap that never fully closed
May Help Prevent the Development of Autoimmune Conditions Chronic inflammation produced by autoimmune conditions leads to oxidative stress
Weekday mornings are easier to remember than Saturday
This complete absence of tolerability-driven discontinuations indicates that even when side effects occurred, they were sufficiently mild that participants chose to continue treatment